Wednesday, May 25, 2016

FibroGen Inc (FGEN) Given “Buy” Rating at Credit Suisse

FibroGen Inc (NASDAQ:FGEN) s stock had its buy rating reissued by Credit Suisse in a report released on Wednesday. Other research analysts also recently issued research reports about the stock. Zacks Investment Research downgraded shares of FibroGen from a hold rating to a sell rating in a research report on Tuesday, May 3rd. Goldman Sachs dropped [ ]